GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

Начало・Списък с акции・Orexo AB

O
Orexo AB

Затворен

21.95 3.29

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

22.7

Ключови измерители
By Trading Economics
Приходи	-68M -116M
Продажби	-115M 3.3M
EPS	20.884
Марж на печалбата	-3,503.03
Служители	72
EBITDA	-262M -272M

Дивиденти
By Dow Jones
Следващи печалби	28.04.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-255M 779M
Предишно отваряне	18.66
Предишно затваряне	21.95

Orexo AB Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.03.2026 г., 18:58 ч. UTC

Значими двигатели на пазара

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24.03.2026 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

24.03.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24.03.2026 г., 23:33 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24.03.2026 г., 23:16 ч. UTC

Пазарно говорене

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24.03.2026 г., 22:40 ч. UTC

Печалби

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24.03.2026 г., 22:40 ч. UTC

Печалби

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24.03.2026 г., 22:40 ч. UTC

Печалби

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24.03.2026 г., 21:44 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

24.03.2026 г., 21:44 ч. UTC

Пазарно говорене

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24.03.2026 г., 20:59 ч. UTC

Печалби

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24.03.2026 г., 20:58 ч. UTC

Значими събития в новините

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Energy & Utilities Roundup: Market Talk

24.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Basic Materials Roundup: Market Talk

24.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

24.03.2026 г., 20:25 ч. UTC

Печалби

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24.03.2026 г., 20:15 ч. UTC

Пазарно говорене

Значими събития в новините

Global Commodities Roundup: Market Talk

24.03.2026 г., 20:10 ч. UTC

Пазарно говорене

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24.03.2026 г., 20:10 ч. UTC

Печалби

Worthington Enterprises 3Q Sales $378.7M >WOR

24.03.2026 г., 20:10 ч. UTC

Печалби

Worthington Enterprises 3Q Adj EPS 98c >WOR

24.03.2026 г., 20:10 ч. UTC

Печалби

Worthington Enterprises 3Q EPS 92c >WOR

24.03.2026 г., 19:25 ч. UTC

Пазарно говорене

Значими събития в новините

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24.03.2026 г., 19:06 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24.03.2026 г., 18:51 ч. UTC

Пазарно говорене

Значими събития в новините

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24.03.2026 г., 18:40 ч. UTC

Пазарно говорене

Значими събития в новините

Global Forex and Fixed Income Roundup: Market Talk

24.03.2026 г., 18:40 ч. UTC

Пазарно говорене

Значими събития в новините

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24.03.2026 г., 18:34 ч. UTC

Значими събития в новините

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24.03.2026 г., 18:27 ч. UTC

Пазарно говорене

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24.03.2026 г., 18:21 ч. UTC

Пазарно говорене

Значими събития в новините

Silver Snaps 9-Session Losing Streak -- Market Talk

24.03.2026 г., 18:00 ч. UTC

Придобивния, сливания и поглъщания

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Orexo AB Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.